Perhexiline
CAS No. 6621-47-2
Perhexiline( —— )
Catalog No. M15523 CAS No. 6621-47-2
Perhexiline is a prophylactic antianginal agent that inhibits carnitine palmitoyltransferase (CPT1/CPT2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1229 | Get Quote |
|
| 50MG | 2507 | Get Quote |
|
| 100MG | 3168 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePerhexiline
-
NoteResearch use only, not for human use.
-
Brief DescriptionPerhexiline is a prophylactic antianginal agent that inhibits carnitine palmitoyltransferase (CPT1/CPT2).
-
DescriptionPerhexiline is a prophylactic antianginal agent that inhibits carnitine palmitoyltransferase (CPT1/CPT2); promotes HER3 ablation through receptor internalization and inhibits tumor growth; activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.Hypertension Phase 2 Clinical.
-
In VitroPerhexiline (5-25 μM, 2-6 h) reduces cell viability in HepG2 cells.Perhexiline (5-25 μM, 2-6 h) reduces cellular ATP content and Lactate dehydrogenase (LDH) release in HepG2 cells.Perhexiline (20 μM, 2 h) activates caspase 3/7 in HepG2 cells.Perhexiline (5-25 μM, 4 h) causes mitochondrial dys function in HepG2 cells.Perhexiline (5 μM, 48 h) selectively induces massive apoptosis in CLL cells (high expression of CPT). Cell Viability Assay Cell Line:HepG2 cells Concentration:5, 10, 15, 25 μM Incubation Time:2, 4, 6 h Result:Induced time- and concentration-dependent cytotoxicity in hepatic cells.Western Blot Analysis Cell Line:HepG2 cells Concentration:5, 10, 15, 25 μM Incubation Time:2 h Result:Reduced Bcl-2 and Mcl-1 level, and increased Bad level.
-
In VivoPerhexiline (200 mg/kg, p.o., daily for 8 weeks) reduces peripheral neural function in female DA rats.Perhexiline (80 mg/kg, oral gavage, for 3 days) demonstrates anti-tumor activity in glioblastoma mouse model. Animal Model:Orthotopic glioblastoma mouse model Dosage:80 mg/kg Administration:Oral gavage, for 3 days. Result:Reduces tumor size (MR imaging) and improves in overall survival.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number6621-47-2
-
Formula Weight277.496
-
Molecular FormulaC19H35N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
-
Chemical Name2-(2,2-dicyclohexylethyl)-piperidine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
WZ3146
WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM; does not inhibit ERBB2 phosphorylation (T798I).
-
Murine CMV pp 89 (16...
IE1 peptide refers to an antigenic peptide encoded by the immediate early (IE) gene of mouse cytomegalovirus (mCMV). IE1 peptide is one of the key antigenic peptides expressed during mCMV infection, plays a role in transcriptional activation in the life cycle of mCMV, and is one of the earliest genes expressed in the viral replication cycle. IE1 peptide is an important target for CD8+ T cell response and can be used to study the host immune response to mCMV infection.
-
pGlu-Pro-Arg-MNA mon...
pGlu-Pro-Arg-MNA monoacetate is a thrombin substrate which has been modeled after a thrombin cleavage site in human fibrinogen, can be used for a sensitive assay of antithrombin III activity.
Cart
sales@molnova.com